Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hess

Showing results (1051-1060 of 1,218) with videos related to

Pageof 122
Sort By:
The Lancet. Oncology|October 6, 2009
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trialEric L Chang, Jeffrey S Wefel, Kenneth R Hess, et al.
Molecular Neurobiology|December 13, 2018
FOXG1 Regulates PRKAR2B Transcriptionally and Posttranscriptionally via miR200 in the Adult HippocampusStefan C Weise, Ganeshkumar Arumugam, Alejandro Villarreal, et al.
Journal of Neuro-Oncology|June 27, 2008
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastomaJ F de Groot, M R Gilbert, K Aldape, et al.
Journal of Radiosurgery and SBRT|January 4, 2018
Internal validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic radiosurgeryGarrett Jensen, Chad Tang, Kenneth R Hess, et al.
Advances in Radiation Oncology|June 13, 2020
Stereotactic Body Radiation Therapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison With Surgery, Tumor Ablation, and ObservationStephen R Grant, Xiudong Lei, Kenneth R Hess, et al.
Oncotarget|August 4, 2016
Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trialsJ Andrew Livingston, Kenneth R Hess, Aung Naing, et al.
Neurocritical Care|September 9, 2016
Cost and Utility of Microbiological Cultures Early After Intensive Care Unit Admission for Intracerebral HemorrhageJonathan Elmer, David Yamane, Peter C Hou, et al.
BMC Cancer|May 20, 2020
Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBCToshiaki Iwase, Kenichi Harano, Hiroko Masuda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiformeV A Levin, J H Uhm, K A Jaeckle, et al.
Environmental Microbiology|December 5, 2014
Genomic and proteomic characterization of two novel siphovirus infecting the sedentary facultative epibiont cyanobacterium Acaryochloris marinaYi-Wah Chan, Andrew D Millard, Peter J Wheatley, et al.
Pageof 122

Showing results (1051-1060 of 1,218) with videos related to

Sort By:
Pageof 122
The Lancet. Oncology|October 6, 2009
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trialEric L Chang, Jeffrey S Wefel, Kenneth R Hess, et al.
Molecular Neurobiology|December 13, 2018
FOXG1 Regulates PRKAR2B Transcriptionally and Posttranscriptionally via miR200 in the Adult HippocampusStefan C Weise, Ganeshkumar Arumugam, Alejandro Villarreal, et al.
Journal of Neuro-Oncology|June 27, 2008
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastomaJ F de Groot, M R Gilbert, K Aldape, et al.
Journal of Radiosurgery and SBRT|January 4, 2018
Internal validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic radiosurgeryGarrett Jensen, Chad Tang, Kenneth R Hess, et al.
Advances in Radiation Oncology|June 13, 2020
Stereotactic Body Radiation Therapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison With Surgery, Tumor Ablation, and ObservationStephen R Grant, Xiudong Lei, Kenneth R Hess, et al.
Oncotarget|August 4, 2016
Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trialsJ Andrew Livingston, Kenneth R Hess, Aung Naing, et al.
Neurocritical Care|September 9, 2016
Cost and Utility of Microbiological Cultures Early After Intensive Care Unit Admission for Intracerebral HemorrhageJonathan Elmer, David Yamane, Peter C Hou, et al.
BMC Cancer|May 20, 2020
Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBCToshiaki Iwase, Kenichi Harano, Hiroko Masuda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiformeV A Levin, J H Uhm, K A Jaeckle, et al.
Environmental Microbiology|December 5, 2014
Genomic and proteomic characterization of two novel siphovirus infecting the sedentary facultative epibiont cyanobacterium Acaryochloris marinaYi-Wah Chan, Andrew D Millard, Peter J Wheatley, et al.
Pageof 122